| Literature DB >> 31086370 |
Sundeep S Dhillon1, Frida Torell2,3,4, Magdalena Donten4, Katrin Lundstedt-Enkel4,5, Kate Bennett4, Stefan Rännar4,6, Johan Trygg2,6, Torbjörn Lundstedt4,7.
Abstract
The zebrafish embryo is a popular model for drug screening, disease modelling and molecular genetics. In this study, samples were obtained from zebrafish at different developmental stages. The stages that were chosen were 3/4, 4/5, 24, 48, 72 and 96 hours post fertilization (hpf). Each sample included fifty embryos. The samples were analysed using gas chromatography time-of-flight mass spectrometry (GC-TOF-MS). Principle component analysis (PCA) was applied to get an overview of the data and orthogonal projection to latent structure discriminant analysis (OPLS-DA) was utilised to discriminate between the developmental stages. In this way, changes in metabolite profiles during vertebrate development could be identified. Using a GC-TOF-MS metabolomics approach it was found that nucleotides and metabolic fuel (glucose) were elevated at early stages of embryogenesis, whereas at later stages amino acids and intermediates in the Krebs cycle were abundant. This agrees with zebrafish developmental biology, as organs such as the liver and pancreas develop at later stages. Thus, metabolomics of zebrafish embryos offers a unique opportunity to investigate large scale changes in metabolic processes during important developmental stages in vertebrate development. In terms of stability of the metabolic profile and viability of the embryos, it was concluded at 72 hpf was a suitable time point for the use of zebrafish as a model system in numerous scientific applications.Entities:
Mesh:
Year: 2019 PMID: 31086370 PMCID: PMC6516655 DOI: 10.1371/journal.pone.0213661
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Process for metabolic profiling of zebrafish embryos.
Sample groups used for modelling.
| Group | Age of embryo (hpf) | Condition | Number of samples |
|---|---|---|---|
| 1 | 3/4 | Untreated | 3 |
| 2 | 4/5 | Untreated | 5 |
| 3 | 24 | Untreated | 5 |
| 4 | 24 | Treated with pronase to remove chorion | 5 |
| 5 | 48 | Treated with PTU to remove pigment | 5 |
| 6 | 72 | Untreated | 5 |
| 7 | 96 | Untreated | 5 |
Fig 2Score plot (t1/t2) for overview model after removal of sample 18_1.
2(A): The score plot showed the developmental stages. The first and second component explained 34% and 22% of the variation respectively. Different colours and shapes were used for the developmental samples: 3/4 hpf–red square, 4/5 hpf–blue rhombus, 24 hpf–black square, 48 hpf–green star, 72 hpf–orange pyramid and 96 hpf–purple triangle. 2(B): The loading plot showed the distribution of the identified metabolites. The metabolites were coloured according to metabolite class.
Quality of discriminant models.
| Model | A | N | R2X | R2Y | Q2 | P-value |
|---|---|---|---|---|---|---|
| Early vs 24 hpf | 1+1+0 | 17 | 0.62 | 0.99 | 0.97 | 3.3*10−9 |
| 24 hpf vs 48 hpf | 1+1+0 | 15 | 0.57 | 0.99 | 0.97 | 6.4*10−8 |
| 48 hpf vs 72 hpf | 1+1+0 | 10 | 0.60 | 0.99 | 0.95 | 1.7*10−3 |
| 72 hpf vs 96 hpf | 1+1+0 | 10 | 0.51 | 0.99 | 0.94 | 0.016 |
A is the number of components. N is the number of samples that the model is based on. R2X and R2Y are the cumulative variations explained in the metabolite and class-variable data respectively. Q2 is the cross-validated prediction estimate of class separation that shows how well samples are predicted by the model. The p-values were obtained using CV-ANOVA in SIMCA 14.0.
Significantly differing metabolites comparing one developmental stage to the next.
| Metabolite | Class | Comparison | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Early vs 24 hpf | 24 hpf vs 48 hpf | 48 hpf vs 72 hpf | 72 hpf vs 96 hpf | ||||||
| p-value | Fold diff | p-value | Fold diff | p-value | Fold diff | p-value | Fold diff | ||
| Ethanolamine | Amine | 3.6*10−5 | 1.2 | ||||||
| Putrescine | Amine | 1.1*10−9 | 1.9 | 2.7*10−4 | 1.2 | ||||
| Spermidine | Amine | 5.0*10−5 | 0.4 | ||||||
| Urea | Amine | 2.7*10−7 | 2.8 | ||||||
| Alanine | Amino acid | 2.7*10−7 | 2.8 | ||||||
| Aspartate | Amino acid | 9.9*10−7 | 0.2 | ||||||
| Glutamate | Amino acid | 7.8*10−10 | 1.7 | 7.4*10−5 | 1.3 | ||||
| Glutamine | Amino acid | 1.6*10−7 | 2.7 | 4.9*10−4 | 1.3 | 3.9*10−5 | 2.1 | ||
| Histidine | Amino acid | 1.7*10−7 | 2.6 | 3.1*10−5 | 1.4 | 1.8*10−4 | 1.7 | 1.1*10−5 | 2.0 |
| Isoleucine | Amino acid | 1.3*10−7 | 2.4 | ||||||
| Leucine | Amino acid | 8.8*10−7 | 2.0 | ||||||
| Lysine | Amino acid | 6.8*10−7 | 2.1 | ||||||
| Methionine | Amino acid | 2.7*10−6 | 2.0 | 1.2*10−6 | 1.4 | ||||
| Ornithine | Amino acid | 6.6*10−8 | 2.4 | 2.5*10−5 | 1.4 | 8.9*10−5 | 1.6 | ||
| Phenylalanine | Amino acid | 2.9*10−12 | 6.7 | 2.0*10−11 | 2.2 | 9.1*10−5 | 0.4 | ||
| Proline | Amino acid | 3.1*10−4 | 1.6 | ||||||
| Pyroglutamate | Amino acid | 1.1*10−5 | 1.6 | 2.0*10−9 | 1.5 | 8.9*10−6 | 1.5 | ||
| Serine | Amino acid | 1.5*10−7 | 2.2 | 3.0*10−6 | 0.6 | ||||
| Threonine | Amino acid | 4.3*10−7 | 2.1 | ||||||
| Tryptophan | Amino acid | 5.9*10−12 | 5.3 | 1.1*10−8 | 1.9 | 1.4*10−4 | 1.4 | ||
| Tyrosine | Amino acid | 8.4*10−11 | 4.3 | 8.6*10−11 | 3.1 | ||||
| Valine | Amino acid | 1.1*10−7 | 2.4 | ||||||
| Creatinine | Amino ketone | 4.2*10−5 | 1.8 | 3.7*10−9 | 2.1 | 1.7*10−4 | 1.8 | 4.7*10−4 | 1.5 |
| Lactate | Cori cycle | 2.4*10−6 | 2.8 | ||||||
| Elaidate | Fatty acid | 6.3*10−6 | 4.7 | ||||||
| n-Docosan-1-ol | Fatty alcohol | 4.4*10−4 | 0.6 | ||||||
| n-Eicosan-1-ol | Fatty alcohol | 2.3*10−4 | 0.6 | ||||||
| Glycerol-3-phosphate | Lipid | 4.0*10−4 | 1.4 | ||||||
| Adenosine-5-monophosphate | Nucleic acid | 1.6*10−4 | 4.8 | ||||||
| Guanine | Nucleic acid | 6.6*10−7 | 0.2 | 6.8*10−5 | 4.8 | 1.1*10−4 | 1.9 | ||
| Hypoxanthine | Nucleic acid | 2.1*10−6 | 0.2 | 4.2*10−5 | 3.8 | 1.0*10−5 | 2.1 | ||
| Inosine | Nucleic acid | 1.3*10−9 | 15.3 | ||||||
| Urate | Nucleic acid | 2.0*10−9 | 42.7 | 3.7*10−7 | 5.4 | 1.8*10−6 | 1.9 | ||
| 4-amino-Butyrate | Organic acid | 1.4*10−12 | 6.0 | 6.6*10−6 | 3.3 | ||||
| Cellotriose | Sugar | 9.0*10−5 | 6.5 | ||||||
| Fructose | Sugar | 2.7*10−4 | 1.4 | 2.2*10−4 | 1.7 | ||||
| Galactose | Sugar | 6.2*10−10 | 3.9 | 1.3*10−5 | 1.9 | 8.4*10−7 | 0.5 | ||
| Glucose | Sugar | 4.0*10−14 | 28.0 | 7.0*10−7 | 0.3 | ||||
| Glucose-6-phosphate | Sugar | 1.1*10−5 | 2.6 | ||||||
| Maltose | Sugar | 5.7*10−4 | 1.4 | ||||||
| Maltotrise | Sugar | 4.7*10−4 | 3.5 | ||||||
| myo-Inositol | Sugar | 1.0*10−10 | 2.8 | 4.6*10−6 | 1.5 | ||||
| Ribose | Sugar | 3.0*10−9 | 3.1 | ||||||
| Citrate | TCA cycle | 7.0*10−6 | 0.4 | ||||||
| alpha-Ketoglutarate | TCA cycle | 5.0*10−4 | 1.8 | ||||||
| Malate | TCA cycle | 2.8*10−5 | 1.6 | ||||||
| Ascorbate | Vitamin | 4.2*10−7 | 0.4 | ||||||
The p-values were calculated using two tailed Student’s t-tests and corrected for multiple testing by Bonferroni method. Fold differences indicated the average metabolite concentration, expressed per 50 embryos, at one developmental stage divided by the concentration at the previous stage. A value above one indicated that this metabolite increased from one developmental stage to the next, while a value below one showed that the metabolite decreased during the same time.